Status:
COMPLETED
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis
Lead Sponsor:
Allergan
Conditions:
Bacterial Conjunctivitis
Eligibility:
All Genders
Up to 31 years
Phase:
PHASE4
Brief Summary
This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age
Eligibility Criteria
Inclusion
- diagnosed with bacterial conjunctivitis
Exclusion
- chemical or foreign body trauma to either eye
- infection in either eye (besides bacterial conjunctivitis)
- white spots in the cornea or ulcers in either eye
- clinical diagnosis of chlamydia or gonorrhea in either eye
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT00464438
Start Date
June 1 2007
End Date
September 1 2008
Last Update
September 21 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sacramento, California, United States
2
Whitby, Ontario, Canada